Tuesday, 2 September
09.00-12.00
S1 Advances in Drug Delivery
Chairs: Tsuneji Nagai, Japan
and Daan Crommelin, The Netherlands
(In honour of Prof. W.I. Higuchi for his lifetime achievements)
a Biophysical! Model approach to drug delivery Norman Ho, USA
b A novel method based on artificial neural networks for optimising transdermal drug delivery systems Kozo Takayama, and Tsuneji Nagai, Japan
c Prodrug approaches for optimisation of drug delivery Brad Anderson, USA
d Unravelling the complexities of the oral absorption process: Predicting human drug absorption Gordon Amidon, USA
09.00-12.00
S2 Advances in Bioanalytical Procedures: New Instruments and New Techniques
Chairs: Toshio Nambara, Japan
and Gordon McKay, Canada
(In honour of Prof. R.T. Coutts for his lifetime achievements)
a A unique edman sequencing method for peptides/proteins containing d-amino acids Kazuhiro Imai, Japan
b Enantiomeric resolution of drugs by capillary electrophoresis Jacques Crommen, Belgium
c Modern spectroscopic techniques in biodiagnostics Ian Smith, Canada
d Highly specific and sensitive analytical procedures for drugs and their metabolites: RIA to tandem mass spectrometry Gordon McKay, Canada
09.00-12.00
S3 Receptor Research Towards Drug Design and Treatment
Chairs: Douwe Breimer, The
Netherlands and Kamal Midha, Canada
(In honour of Prof. E. Mutschler for his lifetime achievements)
a Selective P2-receptor antagonists: Design, pharmacology and therapeutic potential Gnter Lambrechts, Germany
b Research towards drug design and treatment Pieter Timmermans, USA
c Dopamine receptors and antipsychotic drugs: Basics and clinical Philip Seeman, Canada
d Molecular mechanisms governing the selectivity of receptor/g protein interactions Jrgen Wess, USA
09.00-12.00
P1 Developing Optimal Working Relationships with Physicians
Chairs: Leo-Paul Landry,
Canada and Almar Grimsson, Iceland
Sponsored by an educational grant from Amgen Inc.)
a The impact of the role of the pharmacist on the physician George Carruthers, Canada
b Benefits of co-operation between doctors and pharmacists Dick Tromp, The Netherlands
c Future developments: Collaboration or competition? Albert Wertheimer, USA
Panel discussion
12.15-13.00
Update lecture: 1
Impact of cytochrome metabolism in drug safety and efficacy Geoffrey Tucker, UK
14.00-17.00
S4 New Drug Development: New Strategies
Chairs: Vincent Lee, USA and
Elisabeth Vadas, Canada
(Sponsored in part by an educational grant from Sandoz Canada
Inc.)
a Drug discovery George Poste, UK
b Drug absorption assessment William Curatolo, USA
c Drug metabolism assessment Yuichi Sugiyama, Japan
d Drug pre-formulation and formulation Colin Gardner, USA
14.00-17.00
S5 Advances in Scientific Regulations of Medicine
Chairs: Ian McGilveray, Canada
and Ryoji Konishi, Japan
(Sponsored by an educational grant from Hoechst Marion
Roussel)
a Recent advances in pharmaceutical regulation in Japan: Industrial scope Ryoji Konishi, Japan
b Biologicals and biotech substances: advances in public standards development in Europe Jean-Marc Spieser, France
c Use of in-vitro metabolism to predict safety and efficacy problems in developing market application (US) David Greenblatt, USA
d Advances in scientific regulation of medicine Roger Williams, USA
14.00-17.00
P2 Improving the Care of the Diabetic Patient
Chairs: Hermann Ammon, Germany
and Maryann Hopkins, Canada
(Sponsored by an educational grant from Bayer Inc. Canada)
a Issues and challenges in diabetic care Hermann Ammon, Germany
b The role of the pharmacist - A US model Condit Steil, USA
c From guidelines to outcomes for diabetic care Maria Augusta Soares, Portugal
d Diabetes mellitus: New biological markers of long term complications and management of the care of diabetic patients Franois Trivin, France
Panel discussion
14.00-17.00
P3 Responding to Changes in Health Care Systems
Chairs: William Zellmer, USA
and Yves Garipy, Canada
(In honour of Dr. J. Oddis for his liftime achievements)
(Sponsored by an educational grant from Glaxo Wellcome Canada
Inc.)
a Developments in the public-private financing of health care Robert Evans, Canada
b Comparing international trends in health care reform Peter Bogaert, Belgium
c Health care reform a threat or opportunity for pharmacy? Pierre Sado, France
Panel discussion
Wednesday, 3 September
09.00-12.00
S6 Diabetes Therapy - Current Status
Chairs: Bernard Zinman, Canada and Pierre Lefebvre, Belgium
a Physiologic insulin replacement - An elusive goal Bernard Zinman, Canada
b Current management of type II diabetes mellitus Pierre Lefebvre, Belgium
c Insulin treatment from the viewpoint of controlled release and targeting Ryuzo Kawamori, Japan
d Type I diabetes: A reality or a pipe dream? Francine Kaufman, USA
09.00-12.00
S7 Gender Issues
Chairs: Mary Berg, USA and
Donna Stewart, Canada
(Sponsored by an educational grant from Eli Lilly Canada Inc.)
a European studies in womens health Hildgegard Sourgens, Germany
b Gender framework of health research Mary Berg, USA
c Speaker and topic to be announced
d Speaker and topic to be announced
09.00-12.00
P4 Measuring Outcomes of Pharmacy Practice
Chairs: Christopher Kozma, USA and Hanne Herborg, Denmark
a Do we improve patient outcomes? Christopher Kozma, USA
b Are pharmacists value for money? Bert Leufkens, The Netherlands
c Quality of life and patient satisfaction: Outcomes of pharmacy practice Linda MacKeigan, Canada
Panel discussion
12.15-13.00
Update lecture: 2
Taxol and other advances in
cancer treatment Karen Gelmon, Canada
(Sponsored by an educational grant from Bristol-Myers Squibb,
Canada Inc.)
14.00-17.00
S8 Pharmacoeconomics
Chairs: Jim Blackburn, Canada
andAbraham Hartzema, USA
(Sponsored by an educational grant from Glaxo Wellcome Plc.)
a Applying the modelling approach to pharmacoeconomics Brian Rittenhouse, Canada
b A European experience from the manufacturers perspective Jeremy Chancellor, UK
c Evaluation of the pharmaceutical assessment programme at the Canadian Co-ordinating Office for Health Technology Assessment: Protocols, Studies and Products Nicolaas Otten, Canada
d Pharmacoeconomic evaluation - A governmental perspective Andrew Mitchell, Australia
14.00-17.00
P5 Protocols and Guidelines for Pharmaceutical Care:
New Challenges for Pharmacists
Chairs: Linda Stone, UK and
Jim Blackburn, Canada
(Sponsored in part by an educational grant from Sandoz Canada
Inc.)
a Integrating pharmaceutical care, managed care and disease management Lucinda Maine, USA
b Protocol development in primary care Speaker to be announced
c Implementing protocols in primary care Terry Maguire, Northern Ireland
Panel discussion
Thursday, 4 September
09.00-12.00
P6 Self-Medication - The Trend of the Future
Chairs: Peter Noyce, UK and
Barbara Wells, Canada
(Sponsored by an educational grant of Whitehall Robins Inc.)
a Distribution of non-prescription medicines in the information economy David Skinner, Canada
b A patient perspective on self-medication and self-care Maj-Britt Hedvall, Finland
c Advising the self-medicating patient Peter Noyce, UK
d Can we measure the impact of the pharmacists role with respect to self-medication? Speaker to be announced
12.15-13.00
Update lecture: 3
Genes for inherited defects in children and treatment Linda Surh, Canada